World Vaccine Congress Europe 2018
The World Vaccine Congress Europe is the place to be for the latest news and developments in vaccine research – from antimicrobial resistance to...
The pharmaceutical industry responds to the Brexit White Paper
Mike Thompson, chief executive of the Association of the British Pharmaceutical Industry (APBI) and BioIndustry Association’s (BIA) chief executive Steve Bates have issued a...
EMA: Ramp up efforts to ensure EU medicine supply post-Brexit
The European Medicines Agency (EMA) has warned that some companies need to take further action to safeguard the EU medicine supply once the UK...
Medicines for Europe: better access, better health
Medicines for Europe president Marc-Alexander Mahl outlines the challenges facing the generic, biosimilar and value-added medicines industry and its role in achieving sustainable healthcare.
Medicines...
Antibiotic treatment should stop to avoid resistance “tipping point”
New research from the University of Exeter, UK, shows that if antibiotic treatment continues to be used, patients will pass the “tipping point” of...
Health outcomes and the community pharmacist
Ilaria Passarani, secretary general of PGEU, reflects on the invaluable role of the community pharmacist in improving patient health outcomes in Europe.
Every day, some...
Welcome to the Kuopio Center for Gene and Cell Therapy
The Kuopio Center for Gene and Cell Therapy is home to the research and development of new innovative medicines.
The Kuopio Center for Gene and...
Innovative tissue analysis: Munich spin-off project receives Helmholtz funding
Tissue analysis is an essential tool for investigating diseases and is a mainstay in the field of diagnostics. Conventionally, tissue is fixed, sliced into...
AMPK activator O304 – a novel treatment for Type 2 diabetes and diabetic kidney...
The high and increasing unmet patient need in diabetic kidney disease demands new drugs. Betagenon AB has the answer.
Globally, approximately 40% of Type 2...
European Medicines Agency prepares pharmaceutical companies for Brexit
The European Medicines Agency (EMA) and the European Commission have updated their guidance which will help pharmaceutical companies prepare for the UK’s withdrawal from...
Antibody therapy for migraine prevention set for marketing authorisation
The first monoclonal antibody therapy for migraine prevention, Aimovig, has been recommended for marketing authorisation by the European Medicines Agency's (EMA) Committee for Medicinal...
Oesophageal cancer can be prevented by taking two medications
Taking a combination of an anti-reflux medication and a low dose of aspirin can prevent oesophageal cancer in people at higher risk, according to...
Can antidepressants increase the risk of weight gain?
A new study published in The BMJ today has found that long term use of antidepressants is linked to the increase in risk of...
European Commission approves single pill for HIV-1 treatment
The Janssen Pharmaceutical Companies of Johnson & Johnson have today announced that the European Commission has approved JULUCA® (dolutegravir/rilpivirine), a once daily single pill...
EMA recalls multiple sclerosis drug from hospitals and pharmacies
The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the multiple sclerosis drug Zinbryta has been recalled from hospitals and...
Six months of Herceptin good for women with HER2-positive breast cancer
Taking Herceptin for six months could be just as effective as taking it for 12 months in preventing relapse and death, as well as...
NICE recommends Biogen’s Avonex for multiple sclerosis
The National Institute for Heath and Care Excellence (NICE) has announced its recommendation of Biogen’s Avonex® (interferon beta-1a), which is used as an option...
New oral drug can protect cancer patients from venous thromboembolism
Taking one tablet a day could be the key to helping treat cancer patients and protect them from venous thromboembolism (VTE), according to research...
NHS funding could hinder patient’s access to drugs warns King’s Fund
A new report from The King’s Fund has revealed that NHS funding levels are not keeping pace with growth in NHS spending on medicines,...
ECDC highlights future threat of drug-resistant gonorrhoea
Following three cases of antibiotic-resistant gonorrhoea in Europe and Australia, there is concern that the growing threat of drug resistance could lead to untreatable...
